Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 88,845 | 116,680 | 103,468 | 89,432 | 79,943 |
| Cost of Goods | N/A | 897 | N/A | N/A | 2,239 |
| Gross Profit | 88,845 | 115,783 | 103,468 | 89,432 | 77,704 |
| Operating Expenses | 43,447 | 65,296 | 57,852 | 56,719 | 64,716 |
| Operating Income | 45,398 | 51,384 | 45,616 | 32,713 | 13,227 |
| Interest Expense | 7,626 | 7,521 | 7,419 | 7,318 | 7,220 |
| Other Income | 2,586 | 637 | -2,385 | -191 | -2,662 |
| Pre-tax Income | 40,358 | 44,500 | 35,812 | 25,204 | 3,345 |
| Income Tax | 432 | 1,296 | 1,389 | N/A | N/A |
| Net Income Continuous | 39,926 | 43,204 | 34,423 | 25,204 | 3,345 |
| Net Income | $39,926 | $43,204 | $34,423 | $25,204 | $3,345 |
| EPS Basic Total Ops | 0.25 | 0.27 | 0.22 | 0.16 | 0.02 |
| EPS Basic Continuous Ops | 0.25 | 0.27 | 0.22 | 0.16 | 0.02 |
| EPS Diluted Total Ops | 0.25 | 0.27 | 0.21 | 0.16 | 0.02 |
| EPS Diluted Continuous Ops | 0.25 | 0.27 | 0.21 | 0.16 | 0.02 |
| EBITDA(a) | $45,808 | $51,805 | $47,437 | $33,353 | $13,909 |